Palliative Care Market—Forecast till 2027

$4,950$7,250

The global palliative care market is evaluated to reach a significant CAGR of 8.69% during the forecast period to surpass USD 282,307.1 million by the end of 2027.

SKU: MRFR220263 Category: Tag:

Description

Palliative Care Market—Forecast till 2027

Market Overview
The global palliative care market is evaluated to reach a significant CAGR of 8.69% during the forecast period to surpass USD 282,307.1 million by the end of 2027. Palliative care is given to work on the personal satisfaction of patients who have a genuine or dangerous illness, for example, malignant growth, and assists them with feeling more OK with their treatment.

Palliative care might be given to the patient in the medical clinic, a drawn-out care office, a short-term center, or at home under the management of a clinical expert. The expanding rate of dangerous infections, for example, malignant growth and cardiovascular illnesses drive the worldwide palliative care market.

The worldwide palliative care market is becoming because of the expanding number of patients experiencing constant sicknesses, rising instances of irresistible infections, and the enormous number of patients experiencing basic ailment. There is a developing interest in palliative care administrations because of the expanding number of patients encountering injury and the enormous number of street mishaps requiring restoration administrations.

Also, further developing healthcare foundations in creating economies is relied upon to support the market development. Notwithstanding, the absence of mindfulness connected with palliative care is hampering the development of the market. However, the lack of access to palliative care services in some countries is expected to restrain the market.

Segment Overview
The global palliative care market is classified into type, application, and end-user.

Based on the Type segment the global market has been categorized into Hospital Inpatient Care, Hospice Inpatient Care, Nursing Homes, Residential Facility Care, Homecare, and Private Residence Care.

In terms of application, the market is divided into Cardiac Disease, Congestive Heart Failure, Cancer, Chronic Obstructive Pulmonary Disease (COPD), kidney failure, Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Lateral Sclerosis (ALS), and Others.

Based on End-User the global market has been classified into Long Term Care Centers & Rehabilitation Centers, Hospitals & Clinics, Palliative Care Centers, and Home Care Settings.

Regional Analysis
The Americas represented the largest market share of 37.0% in 2020 and it is likely to dominate the market in the future. The regional market is attributed to the huge number of patients experiencing basic sickness and the difficulties in ongoing illnesses.

Europe is relied upon to display a CAGR of 9.10% during the estimated time frame. As per Eurostat, 20.6% of the populace in the European Union were matured 65 or more in 2020. The geriatric populace is more inclined to experience constant illnesses, which builds the interest for palliative care in the locale.

Asia-Pacific, with nations like China, India, Japan, the Republic of Korea, and Australia, is relied upon to develop at the most elevated CAGR in the market and would go on with this pattern through the estimated time frame. The Middle East and Africa area is assessed to show amazing development because of the presence of low-and center pay nations and deficient healthcare frameworks.

Major Players
The Key Companies listed in the global palliative care market include Vitas Healthcare Corporation (US), Sunrise Senior Living, LLC (US), Home Instead, Inc. (US), Amedisys, Inc. (US), Genesis Healthcare, Inc. (Germany), LHC Group, Inc. (Germany), Revera Inc. (US), FC Compassus LLC (Japan), Kindred Healthcare (Sweden), and Seymour Health (US).

COVID 19 Impacts
We are continuously tracking the impact of COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING INSTANCES OF LIFE-THREATENING DISEASES

4.2.2 GROWING NUMBER OF PALLIATIVE CARE CENTERS WORLDWIDE

4.3 RESTRAINT

4.3.1 LACK OF ACCESS TO PALLIATIVE CARE SERVICES IN DEVELOPING AND UNDERDEVELOPED COUNTRIES

4.4 OPPORTUNITY

4.4.1 GROWING GERIATRIC POPULATION

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)

5.1.2 SERVICE CUSTOMIZATION

5.1.3 CUSTOMER PURCHASE SUPPORT

5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON PALLIATIVE CARE MARKET

5.3.1 OVERVIEW

5.3.2 IMPACT ON DEMAND FOR PALLIATIVE CARE

6 GLOBAL PALLIATIVE CARE MARKET, BY TYPES

6.1 INTRODUCTION

6.2 HOSPITAL INPATIENT CARE

6.3 HOSPICE INPATIENT CARE

6.4 NURSING HOMES

6.5 RESIDENTIAL FACILITY CARE

6.6 HOMECARE

6.7 PRIVATE RESIDENCE CARE

7 GLOBAL PALLIATIVE CARE MARKET, BY APPLICATION

7.1 INTRODUCTION

7.2 CARDIAC DISEASE

7.3 CONGESTIVE HEART FAILURE (CHF)

7.4 CANCER

7.5 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

7.6 KIDNEY FAILURE

7.7 ALZHEIMER’S DISEASE

7.8 PARKINSON’S DISEASE

7.9 AMYOTROPHIC LATERAL SCLEROSIS (ALS)

7.10 OTHERS

8 GLOBAL PALLIATIVE CARE MARKET, BY END USER

8.1 INTRODUCTION

8.2 LONG TERM CARE CENTERS & REHABILITATION CENTERS

8.3 HOSPITALS & CLINICS

8.4 PALLIATIVE CARE CENTERS

8.5 HOME CARE SETTINGS

9 GLOBAL PALLIATIVE CARE MARKET, BY REGION

9.1 INTRODUCTION

9.2 AMERICAS

9.2.1 NORTH AMERICA

9.2.1.1 US

9.2.1.2 CANADA

9.2.2 SOUTH AMERICA

9.3 EUROPE

9.3.1 WESTERN EUROPE

9.3.1.1 GERMANY

9.3.1.2 UK

9.3.1.3 FRANCE

9.3.1.4 ITALY

9.3.1.5 SPAIN

9.3.1.6 REST OF WESTERN EUROPE

9.3.2 EASTERN EUROPE

9.4 ASIA-PACIFIC

9.4.1 CHINA

9.4.2 JAPAN

9.4.3 INDIA

9.4.4 AUSTRALIA

9.4.5 SOUTH KOREA

9.4.6 REST OF ASIA PACIFIC

9.5 MIDDLE EAST & AFRICA

9.5.1 MIDDLE EAST

9.5.2 AFRICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL PALLIATIVE CARE MARKET

10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PALLIATIVE CARE MARKET

10.5 KEY DEVELOPMENT ANALYSIS

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 MERGER/ACQUISITION

10.6.2 COLLABORATION/ AGREEMENT

10.6.3 EXPANSION/INVESTMENT

10.7 FINANCIAL MATRIX

10.7.1 SALES (USD MILLION), 2020

11 COMPANY PROFILES

11.1 VITAS HEALTHCARE CORPORATION

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS/SERVICES OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 SUNRISE SENIOR LIVING, LLC

11.2.1 COMPANY OVERVIEWS

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS/SERVICES OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 KEY STRATEGIES

11.3 HOME INSTEAD, INC.

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS/SERVICES OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 KEY STRATEGIES

11.4 AMEDISYS, INC.

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 SWOT ANALYSIS

11.4.6 KEY STRATEGIES

11.5 GENESIS HEALTHCARE, INC.

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 WOT ANALYSIS

11.5.6 KEY STRATEGIES

11.6 LHC GROUP, INC.

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 SWOT ANALYSIS

11.6.6 KEY STRATEGIES

11.7 REVERA INC.

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 KEY STRATEGIES

11.8 FC COMPASSUS LLC.

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS/SERVICES OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.8.6 KEY STRATEGIES

11.9 KINDRED HEALTHCARE INCORPORATED

11.9.1 COMPANY OVERVIEWS

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS/SERVICES OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 SWOT ANALYSIS

11.9.6 KEY STRATEGIES

11.10 SEYMOUR HEALTH

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS/SERVICES OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

Companies Mentioned

Vitas Healthcare Corporation (US)
Sunrise Senior Living
LLC (US)
Home Instead
Inc. (US)
Amedisys
Inc. (US)
Genesis Healthcare
Inc. (Germany)
LHC Group
Inc. (Germany)
Revera Inc. (US)
FC Compassus LLC (Japan)
Kindred Healthcare (Sweden)
and Seymour Health (US)

Reviews

There are no reviews yet.

Be the first to review “Palliative Care Market—Forecast till 2027”

[class^="wpforms-"]
[class^="wpforms-"]